BCRX NASDAQ
BioCryst Pharmaceuticals, Inc.
1W: -12.5%
1M: -7.1%
3M: +12.3%
YTD: +11.6%
1Y: -19.0%
3Y: -1.1%
5Y: -34.8%
$8.29
-0.08 (-0.96%)
Weekly Expected Move ±7.9%
$8
$8
$9
$10
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$886M
Revenue
+75.9% YoY
$-458M
Net Income
-756.5% YoY
$294M
Free Cash Flow
+1192.0% YoY
-349.5%
Gross Margin
-448.6%
Op. Margin
-461.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE153.9%
ROA-91.2%
ROIC-361.6%
Valuation
P/E-4.4
P/B-3.6
EV/EBITDA-6.7
Leverage
Debt/Equity-4.01
Current Ratio2.06
Interest Cov.-5.1x
Quality Scores
Piotroski F4/9
Altman Z-2.14
Beneish M-9.40